SciELO - Scientific Electronic Library Online

 
vol.22 número2Asbestosis no ocupacional: un riesgo potencial que tener en consideración índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista americana de medicina respiratoria

versión On-line ISSN 1852-236X

Resumen

PALMERO, Domingo et al. Practical Pharmacological Aspects of Drugs Used for the Treatment of Drug-Resistant Tuberculosis in Adults and Children. Rev. am. med. respir. [online]. 2022, vol.22, n.2, pp.264-270. ISSN 1852-236X.

The emergence of resistant strains of Mycobacterium tuberculosis to multiple drugs and the difficulties of their diagnosis and treatment constitute a challenge to global public health. To face this challenge, new anti-tuberculosis drugs, such as bedaquiline, pretomanid, and delamanid, as well as replacement drugs, such as fluoroquinolones, linezolid and clofazimine, are used. Based on the evidence provided by multicenter studies, drugs associated with a better prognosis of drug-resistant tuberculosis have been discovered and, recently, a new classification has been proposed, as well as new totally oral regimens. In this review, we describe current treatment regimens and practical pharmacological aspects required when prescribing new drug-resistant tuberculosis treatment regimens.

Palabras clave : Tuberculosis; Drug-resistance; MDR-TB; Pharmacology.

        · resumen en Español     · texto en Inglés     · Inglés ( pdf )